Polycythemia Vera (PV) is a chronic and rare condition that significantly increases the risk of thrombotic events and cardiovascular complications. Despite existing therapies, many patients do not achieve optimal disease control. Each regional dinner meeting will explore the possibilities of enrolling patients in the VERIFY study, a clinical trial that is investigating the potential of rusfertide as a treatment option for this vulnerable patient population.
Join us for an informative evening near you for a discussion with a VERIFY investigator, where we will delve into the intricacies of PV and review the eligibility criteria for patients interested in participating in this study.
